Role of Angiotensin II and Oxidative Stress in Renal Inflammation by Hypernatremia: Benefits of Atrial Natriuretic Peptide, Losartan, and Tempol
Overview
Affiliations
The body regulates plasma sodium levels within a small physiologic range, despite large variations in daily sodium and water intake. It is known that sodium transport in the kidneys plays an important role in hypoxia, being the major determinant of renal oxygen consumption. Tubular epithelial cell hypoxia is an important contributor to the development of renal inflammation, and the damage may progress to structural injury, ending in acute renal failure. In this review, we will summarize the renal inflammatory effects of high acute plasma sodium (acute hypernatremia), and the molecular mechanisms involved. We will also discuss recent findings related to the role of oxidative stress and angiotensin II (Ang II) in the pathogenesis of renal injury. We will comment on the effects of agents used to prevent or attenuate the inflammatory response, such as the atrial natriuretic peptide, the superoxide dismutase mimetic - tempol, and losartan.
Chen C, Guo J, Chou R, Wu C, Kuo C, Wei J Sci Rep. 2024; 14(1):19848.
PMID: 39191876 PMC: 11349996. DOI: 10.1038/s41598-024-70587-0.
Eraslan Doganay G, Doganci M, Yurtseven G, Ozanbarci A, Kahraman A, Cirik M Medicina (Kaunas). 2024; 60(7).
PMID: 39064448 PMC: 11278994. DOI: 10.3390/medicina60071019.
Effects of elevation of ANP and its deficiency on cardiorenal function.
Ilatovskaya D, Levchenko V, Winsor K, Blass G, Spires D, Sarsenova E JCI Insight. 2022; 7(9).
PMID: 35380994 PMC: 9090260. DOI: 10.1172/jci.insight.148682.
Clues and new evidences in arterial hypertension: unmasking the role of the chloride anion.
Kouyoumdzian N, Kim G, Rudi M, Rukavina Mikusic N, Fernandez B, Choi M Pflugers Arch. 2021; 474(1):155-176.
PMID: 34966955 DOI: 10.1007/s00424-021-02649-5.
Polina I, Domondon M, Fox R, Sudarikova A, Troncoso M, Vasileva V Am J Physiol Renal Physiol. 2020; 319(1):F63-F75.
PMID: 32463726 PMC: 7468826. DOI: 10.1152/ajprenal.00125.2020.